CPX — capsensixx AG Income Statement
0.000.00%
- €60.40m
- €51.31m
- €158.29m
- 91
- 57
- 84
- 94
Annual income statement for capsensixx AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 110 | 180 | 120 | 127 | 158 |
Cost of Revenue | |||||
Gross Profit | 24.2 | 26.5 | 28.3 | 29.6 | 31.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 104 | 172 | 111 | 120 | 151 |
Operating Profit | 6.17 | 7.77 | 8.76 | 6.95 | 7.31 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.5 | 8.71 | 8.63 | 7.79 | 7.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.65 | 6.25 | 6.12 | 5.58 | 5.64 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.39 | 3.25 | 3.28 | 2.64 | 2.79 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.39 | 3.24 | 3.28 | 2.64 | 2.79 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.699 | 0.945 | 0.92 | 0.96 | 0.96 |
Dividends per Share |